US Broker Ratings

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Giant with 144% Revenue Growth and Strong Buy Ratings

Ascendis Pharma A/S (NASDAQ: ASND), a biopharmaceutical company based in Hellerup, Denmark, is capturing investor attention with its impressive revenue growth and a unanimous buy rating from analysts. Operating primarily..

Chemed Corp (CHE) Stock Analysis: A Resilient Healthcare Player with Strong ROE and Modest Dividend Yield

For investors eyeing the healthcare sector, Chemed Corp (NYSE: CHE) represents a compelling opportunity with its dual focus on hospice care and essential home services. With a market capitalization of..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a 33.89% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry in the United States. With a market capitalization..

McKesson Corporation (MCK): Investor Outlook on Healthcare Distribution Giant with 16.89% Potential Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and compelling growth prospects. As a leader in the medical..

DaVita Inc. (DVA) Stock Analysis: Strong ROE and Growth Potential in Healthcare Sector

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector specializing in kidney dialysis services, presents a compelling case for investors with its robust financial metrics and strategic positioning..

STERIS plc (STE) Stock Analysis: Unveiling a Promising 18.92% Potential Upside

In the realm of healthcare, STERIS plc (NYSE: STE) stands out as a formidable player in the medical devices industry, with a market capitalization of $21.05 billion. Headquartered in Mentor,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 48% Potential Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, has captured investor attention with its robust pipeline of therapies targeting life-threatening rare diseases. Headquartered in San Rafael,..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 12.66% Potential Upside in the Healthcare Sector

Doximity, Inc. (NASDAQ: DOCS) is drawing attention from individual investors as it navigates the volatile waters of the healthcare sector. With a market capitalization of $3.98 billion, this health information..

Incyte Corporation (INCY): Investor Outlook on Strong Revenue Growth and Strategic Partnerships

Incyte Corporation (NASDAQ: INCY) is capturing the attention of investors with its robust performance metrics and strategic positioning within the biotechnology sector. As a biopharmaceutical powerhouse, Incyte is dedicated to..

Bio-Techne Corp (TECH) Stock Analysis: Navigating the Biotechnology Landscape Amidst Revenue Challenges

Bio-Techne Corp (NASDAQ: TECH) has firmly positioned itself within the biotechnology sector, a domain known for its high-stakes innovation and significant market volatility. With a market capitalization of $11.11 billion,..

Becton, Dickinson and Company (BDX) Stock Analysis: A 16% Upside Opportunity in the Healthcare Sector

As individual investors explore opportunities in the diverse landscape of healthcare, Becton, Dickinson and Company (NYSE: BDX) presents a compelling case for consideration. With a robust market cap of $41.87..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 24.81% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), headquartered in Piombino Dese, Italy, stands as a significant contender in the healthcare sector, specifically within the medical instruments and supplies industry. As of the..

Eli Lilly and Company (LLY) Stock Analysis: Exploring the Potential Within a $1.06 Trillion Market Cap Giant

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, is making waves with its impressive market presence and innovative pharmaceutical offerings. With a staggering market capitalization of..

Masimo Corporation (MASI): Analyst Consensus and Growth Potential in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices industry, continues to capture investor attention with its innovative patient monitoring technologies. Headquartered in Irvine, California, Masimo is known..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Evaluating a 26.70% Potential Upside with Strong Buy Ratings

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector, stands as a prominent player in the drug manufacturing industry with a market capitalization of $52.88 billion. Headquartered..

Amgen Inc. (AMGN) Stock Analysis: Navigating a Sturdy Healthcare Giant with a 2.77% Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to stand out amidst the bustling landscape of drug manufacturers. With a market capitalization of $196.12 billion, Amgen’s robust..

Regeneron Pharmaceuticals (REGN): Investor Outlook on Its 23.77% Potential Upside

Regeneron Pharmaceuticals, Inc. (REGN), a heavyweight in the biotechnology sector, is garnering attention from investors due to its considerable market presence and promising growth potential. Currently trading at $664.52, the..

DexCom, Inc. (DXCM) Stock Analysis: Strong Analyst Consensus and Promising Growth Potential

DexCom, Inc. (NASDAQ: DXCM) stands as a key player in the healthcare sector, specifically within the medical devices industry, focusing on the development and commercialization of continuous glucose monitoring (CGM)..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a Potential 22.42% Upside with Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY) offers a compelling investment opportunity in the healthcare sector, primarily focusing on health information services. With a current market capitalization of $7.89 billion, this U.S.-based company..

Bristol-Myers Squibb (BMY): Investor Outlook on Growth Potential and Dividend Stability

Bristol-Myers Squibb Company (NYSE: BMY) remains a significant player in the healthcare sector, with a focus on the development and distribution of biopharmaceutical products. As a key entity within the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds